Giuseppe Ciaramella - 22 Dec 2021 Form 4 Insider Report for Beam Therapeutics Inc. (BEAM)

Role
President & CSO
Signature
By: /s/ Christine Bellon, Attorney-in-fact
Issuer symbol
BEAM
Transactions as of
22 Dec 2021
Net transactions value
-$205,709
Form type
4
Filing time
23 Dec 2021, 17:00:32 UTC
Previous filing
22 Dec 2021
Next filing
30 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BEAM Common Stock Options Exercise $18,823 +2,607 +4.2% $7.22 65,380 22 Dec 2021 Direct F1
transaction BEAM Common Stock Sale $103,834 -1,216 -1.9% $85.39 64,164 22 Dec 2021 Direct F2, F3
transaction BEAM Common Stock Sale $95,369 -1,101 -1.7% $86.62 63,063 22 Dec 2021 Direct F2, F4
transaction BEAM Common Stock Sale $25,329 -290 -0.46% $87.34 62,773 22 Dec 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BEAM Stock Option (Right to Buy) Options Exercise $0 -2,607 -2.8% $0.000000 89,646 22 Dec 2021 Common Stock 2,607 $7.22 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Each sale price reported is a weighted average price. The Reporting Person undertakes to provide Beam Therapeutics Inc. ("BEAM"), any security holder of BEAM or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $85.00 to $85.88, inclusive.
F4 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $86.15 to $86.99, inclusive.
F5 The option vests as to 25% on the first anniversary of the of the vesting commencement date, October 1, 2019, and at a rate of 2.78% each month thereafter until the option is fully vested.